Founded in 2020, Orcosa Inc. is a life sciences company dedicated to modernizing medicine intake and enhancing patient outcomes through its proprietary therapeutic delivery technology, Rapid Infusion Technology (RITe™). The company focuses on developing innovative drug absorption solutions and offers products such as ORAVEXX™, a cannabinoid composition for pain and inflammation management. Orcosa's market focus includes improving therapeutic delivery methods in the pharmaceutical industry.
Orcosa has secured key patents for its technologies, including ORAVEXX™, from the United States Patent and Trademark Office. The company maintains end-to-end control over formulation, development, and manufacturing processes. By partnering with leading research institutions, Orcosa has made significant strides in therapeutic delivery technology, contributing to better patient care and outcomes.
